Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AUTO-6NG by Autolus Therapeutics for Glioma: Likelihood of Approval
AUTO-6NG is under clinical development by Autolus Therapeutics and currently in Phase I for Glioma. According to GlobalData, Phase I...